American Association for Cancer Research

SHERPA: Unknown

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Fuks
    Fuks
  4. Blasberg
    Blasberg
  5. Chiosis
    Chiosis
  6. Scher
    Scher
  7. Kolesnick
    Kolesnick
  8. Scheinberg
    Scheinberg
  9. Haimovitz-Friedman
    Haimovitz-Friedman
  10. Sadelain
    Sadelain

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (492)
  2. Sloan Kettering Institute Faculty (492)
  3. GSK Faculty (424)
  4. Department of Medicine (335)
  5. Solid Tumor Oncology Division (212)
  6. Breast Medicine Service (153)
  7. Sloan Kettering Institute Postdocs (141)
  8. Center for Hematologic Malignancies (131)
  9. Hematologic Malignancies Research (119)
  10. Human Oncology and Pathogenesis Program (118)
Search Within
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (243)
  2. Meeting Abstract (242)
  3. Conference Paper (5)
  4. Editorial (2)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (492)
  2. Sloan Kettering Institute Faculty (492)
  3. GSK Faculty (424)
  4. Department of Medicine (335)
  5. Solid Tumor Oncology Division (212)
  6. Breast Medicine Service (153)

More Groups

People
  1. Neal Rosen (142)
  2. David Solit (67)
  3. Steven Larson (63)
  4. Zvi Fuks (43)
  5. Ronald Blasberg (42)
  6. Gabriela Chiosis (40)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (15)
  5. 2021 (13)
  6. 2020 (17)

More Years

Publications
  1. Cancer Research (340)
  2. Clinical Cancer Research (152)

Results (492)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Dotting out AML by targeting fibrillarin
    Editorial

    Luo, H.; Kharas, M. G.
    Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Epigenetic cooperativity as a therapeutic vulnerability in cancer
    Editorial

    Kazansky, Y.; Kentsis, A.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SMYD2 regulates chromatin modifier KMT2D in ER+/PIK3CA mutant breast cancer
    Meeting Abstract

    Blawski, R.; Sallaku, M.; Guo, X.; Kittane, S.; Scaltriti, M.; Luo, M.; Toska, E.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MEKi-FGFRi combination nanoparticles for use against KRAS(mt)/FGFR-compensatory lung tumors
    Meeting Abstract

    Izawa-Ishiguro, A. R.; Sridharan, R.; Wun, C.; Sami, T. J.; Heller, D. A.
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: